Interview with Glib Zagoriy, CEO, Darnitsa
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Address: ZAO Darnitsa Pharmaceutical Firm, 13 Ulitsa Borispolskaya, Kiev, 02093,Ukraine
Tel: (+38 044) 207-73-18
Web: http://darnitsa.ua/
In October 1930 the Ukrainian Institute of Experimental Endocrinology was founded in the Ukrainian capital Kiev. Few people then knew that the new buildings of the institute, built in 1938 in the Darnytskyi district of the capital, would be the basis of the largest chemical and pharmaceutical association in Ukraine. Darnitsa gave a powerful impetus to the development of modern pharmaceutical industry in Ukraine. The modern history of the company began in 1994, when the company was significantly reorganized.
Darnitsa’s use of innovative technologies and equipment along with compliance with the GMP and the introduction of quality management guarantees the production of a wide range of products under controlled conditions and ensures flexibility and mobility of production, optimal pricing and high quality and efficiency.
Darnitsa invest a significantly, not only in research and technology development, but also in the development of human resources. Effective use of the intellectual capacity of the staff – that the success of their business.
Antibiotics
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Petro Bagriy, president of the Association of Drug Manufacturers of Ukraine (AMMU), which gathers seven of the leading Ukrainian pharmaceutical companies, provides insights into the internal workings of the association…
Robert Chagalian, country manager of Siemens Healthineers Ukraine, provides a fascinating insight into the 165-year long presence of Siemens on the Ukrainian market, whilst highlighting the strong commitment of the…
Aleksandr Iavorskyi, founder and president of Biocon, Ukraine’s leading third-party logistics (3PL) company in the pharmaceutical and healthcare areas, provides insights into Biocon’s impressive development and unique partnership approach as…
Victoria Bandyk, chief operating officer of the Bioscience Group, provides insights into the unique added value and the international development of this comprehensive group of companies, which aims to support…
Roman Gladkyi, general manager of Ferring Ukraine, describes the current opportunities and areas for improvement he identifies within Ukraine’s pharmaceutical market and the country’s evolving heath system, with a special…
Evgeniy Gaydukov, Country Director of AstraZeneca Ukraine, provides insights into the remarkable growth that the science-led, innovative company has been experiencing in Ukraine despite the unstable economic situation in the…
Anatoliy Novyk, founder and president of SMC Ecopharm, the only Ukrainian pharmaceutical company to be exclusively focused on its own original drug development, provides insights into Ecopharm’s promising expansion strategy,…
Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as…
Taras Velgosh, Adamed’s country manager in Ukraine, provides insights into the great results accomplished by the Ukrainian affiliate of this leading Polish pharmaceutical company despite the deep crisis that has…
Liana Maksyoutova, country manager of Polpharma Ukraine, provides insights into the impressive transformation of the Ukrainian affiliate that she has fostered since inheriting its reins in 2012 and how she…
Anatoliy Reder, founder and general director of InterChem, provides insights into the heightened international ambitions of this leading, science-based Ukrainian pharmaceutical company, which plans to leverage its unique R&D and…
Natalia Zago, managing director of Takeda Ukraine, one of the leading international companies operating in the country, provides insights into her main priorities to drive the growth of the company…
See our Cookie Privacy Policy Here